Washington Drug Letter
Aug. 1, 2011
| Vol.
43 No.
30
FDA Requests Additional Warnings on OTC Bronchodilator Drug Labels
The FDA is asking drugmakers to change the label for OTC bronchodilator drugs, updating the warnings to remind patients their blood pressure or heart rate could go up, which could increase the risk of heart attack, stroke or death.
This article is viewable by subscribers only. To view this article, please select an option below.
|